Study to Evaluate SHR6390 Combined With Pyrotinib in Patients With HER2 Positive Gastric Cancer
Clinical trial NCT03480256 · UNKNOWN
Trial details
- NCT number
- NCT03480256
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-27
- Primary completion
- 2019-11-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.